News & Analysis as of

Healthcare Investment Investors

McGuireWoods LLP

Frontiers in Women’s Health: Where Investor Opportunities Meet Unmet Need

McGuireWoods LLP on

For years, women’s health was often siloed into OB/GYN care and absent from mainstream investment theses, but that landscape is changing. New platforms and care models are addressing women’s health in a more comprehensive...more

McDermott Will & Schulte

McDermott HealthEx 2025: McKinsey Key Takeaways

McDermott HealthEx convened more than 1,300 of the most influential leaders in healthcare and life sciences. The event emphasized creativity, transformation, and growth, with sessions dedicated to innovation, AI-powered...more

McDermott Will & Schulte

Market Update: Investments in Healthcare Education on the Rise

Partners Julia Boyd, Marshall Jackson, Jr., and Gregory Metz explored the increasing investment activity at the intersection of education and healthcare during a recent panel that featured Dina Said Dwyer, founder of Eden...more

McDermott Will & Schulte

European Health & Life Sciences Symposium 2025: Key Takeaways

In April 2025, we were proud to host the annual European Health & Life Sciences Symposium at the Shangri-La hotel in Paris. Attended by some 300 delegates from across the industry, participants including investors,...more

McGuireWoods LLP

Healthcare & Life Sciences Private Equity Deal Tracker: New Mountain Invests in Office Ally

McGuireWoods LLP on

New Mountain Capital has completed a growth investment in Office Ally, according to a news release....more

Knobbe Martens

Boston Scientific Agrees to Acquire Sonivie Ltd. For up to $540 Million

Knobbe Martens on

Boston Scientific recently announced it entered into a definitive agreement to acquire SoniVie Ltd. According to the press release, SoniVie is a privately held medical device company that developed the TIVUS Intravascular...more

Mintz Edge

The State of the Funding Market for AI Companies: A 2024 - 2025 Outlook

Mintz Edge on

Artificial intelligence (AI) has emerged as an influential technology, driving notable investments across various industries in recent years. In 2024, venture capital (VC) funding for AI companies reached record levels,...more

Knobbe Martens

BD Announces Restructuring to Focus on Medical Technology

Knobbe Martens on

On February 5, 2025, Becton, Dickinson and Company (BD) announced plans to separate its Biosciences and Diagnostic Solutions business into an independent entity. The Biosciences and Diagnostic Solutions business is reportedly...more

Knobbe Martens

Heading Towards an Optimistic Initial Public Offerings (IPOs) Resurgence in 2025?

Knobbe Martens on

On January 16th, 2025, GT Medical Technologies, announced that it has raised $37 million in Series D financing round. The financing round was led by Evidity Health Capital and joined by Accelmed Partners. Current investors...more

Sheppard Mullin Richter & Hampton LLP

Four Takeaways from the Orthopedics Today Conference 2025

Sheppard Mullin partners, Cyrus Abbassi and Leonard Lipsky, served as panelists at the annual Orthopedics Today Conference in Kauai, Hawaii, held in January 2025. During a spirited discussion with various stakeholders in the...more

Bass, Berry & Sims PLC

State Legislatures Target Private Equity Investments and Corporate Structures in Health Care with New Bills

Many state legislatures have recently convened for 2025 legislative sessions, and members have already proposed a significant number of bills that, if passed, would materially impact transactions and/or corporate structures...more

Foley & Lardner LLP

Drilling Down into Venture Capital Financing in Artificial Intelligence

Foley & Lardner LLP on

It should come as no surprise that venture capital (VC) investors are drilling down into startups building businesses with Artificial Intelligence (AI) at the core. New data from PitchBook actually shows that AI startups make...more

McDermott Will & Schulte

Massachusetts H.5159 Seeks to Reshape Private Equity in Healthcare

On December 30, 2024, both the Massachusetts House of Representatives and the Massachusetts Senate enacted House Bill 5159 (H.5159), and Governor Maura Healey signed it on January 8, 2025. The bill seeks to strengthen...more

Goodwin

The 43rd Annual J.P. Morgan Healthcare Conference Starts Today - A Who’s Who in Biologics at this Year’s Conference

Goodwin on

The JP Morgan Healthcare Conference (“JPM”) “is the largest and most informative health care investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative technology...more

Bass, Berry & Sims PLC

Healthcare Private Equity Outlook & Trends - January 2025

Bass, Berry & Sims PLC on

As some packed the skis and headed to their favorite slopes this winter season, it is hard not to see the analogies to the healthcare private equity (PE) transaction market as we ring in the New Year. Much like the Northern...more

McDermott Will & Schulte

Key Takeaways | Market Access and Reimbursement – Opportunities and Challenges

During this session, the panelists discussed the role of market access in making investment decisions within the healthcare sector. The conversation covered various aspects, including the importance of early market access...more

McDermott Will & Schulte

Key Takeaways | State of the Market – Still Looking for an Exit

During this session, the panelists discussed notable developments within the life sciences industry with a specific focus on the GLP-1 drug market and its opportunities for improvement in patient satisfaction and dosage. They...more

J.S. Held

Inside the Healthcare Industry: Challenges Facing Investors, Lenders, and Leaders of Behavioral Health Companies

J.S. Held on

Behavioral health is a hot area in the healthcare sector, and for good reason. Globally and nationally, society has failed to figure out how to effectively address and prevent the world’s behavioral health crisis. As a...more

Foley & Lardner LLP

Private Equity Investments in Oncology: Top Five Things to Know

Foley & Lardner LLP on

Although private equity (PE) sponsors have been active investors in the health care services industry for the last decade, PE-backed health care providers today constitute only 4% of the United States health market by...more

Bass, Berry & Sims PLC

Health Care Investors Conference: 2024 Recap

Bass, Berry & Sims PLC on

Bass, Berry & Sims, Deloitte and Harris Williams proudly co-hosted the 14th annual Health Care Investors Conference (HCIC) on October 9 as an associated event of the Nashville Healthcare Sessions conference....more

McDermott Will & Schulte

Private Markets Update | Summer 2024

McDermott Will & Schulte on

The Private Markets Update highlights key developments emerging from private markets across Europe, the UK and the United States, exploring the cross-border issues that matter to investors and sponsors in alternative assets. ...more

Mintz - Health Care Viewpoints

Health Law Diagnosed – Women Leaders in Health Care: Investing in Women’s Health

In the latest episode of Health Law Diagnosed – Women Leaders in Health Care, a series that brings together women leaders for discussions on timely key issues and reflections on developing a career in the industry, host...more

McDermott Will & Schulte

HPE Europe 2024: Key Takeaways

On 19 September 2024, we were once again delighted to assemble hundreds of healthcare professionals, investors, and industry changemakers at The Langham  in London for our annual Healthcare Private Equity (HPE) Europe...more

Robinson+Cole Health Law Diagnosis

California Governor Vetoes Bill Imposing New Requirements for Private Equity in Healthcare Transactions

On September 28, 2024, California Governor Gavin Newsom vetoed California Assembly Bill 3129 (the Bill). The Bill, if enacted, would have imposed new notice and consent requirements for private equity investors involved in...more

A&O Shearman

Key takeaways from the LSX World Congress USA

A&O Shearman on

On September 11-12, we had the pleasure of attending the LSX World Congress USA in Boston, where leaders discussed the challenges and opportunities of M&A and partnerships in the pharmaceutical sector....more

112 Results
 / 
View per page
Page: of 5

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide